AzTrials
AzTrials

Diabetes Mellitus, Type 1NCT05107544

Metabolic, Physical Fitness and Mental Health Effects of High Intensity Interval Training (HIIT) in Adolescents With Type 1 Diabetes

A study testing HIGH INTENSITY INTERVAL TRAINING in people with Diabetes Mellitus, Type 1, run by Hospital Las Higueras at 1 site in Chile.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients with type 1 diabetes usually present cardiovascular risk factors. Sixty percent of them are overweight or obese, 40% have hypertension, 60% have dyslipidemia, leading to cardiovascular disease as the major cause of death in adults with type 1 diabetes. Read more about this study

Who is it for?
Ages 12 to 19 years
Conditions the study is for
Diabetes Mellitus, Type 1
What is being tested?
HIGH INTENSITY INTERVAL TRAINING
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteChile
Study dates
4 Sep 2021to 4 Apr 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 19 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Adolescents with type 1 diabetes
  • Ages: 12-19 years (and in pubertal stage of at least Tanner stage III breast or genitalia)
  • HbA1c between 7 and 11.5%
  • Total daily insulin dose ≥0.7 units/kg/day.
  • Both genders
  • Patients treated regularly at Las Higueras Hospital and Guillermo Grant Benavente Hospital.

Who cannot join

  • < 1 year of diabetes
  • Any medical, mental or physical disability that contraindicates exercise.
  • Practice of regular, structured and planned physical exercise outside the project, more than 2 times a week.
  • Pregnancy or breastfeeding
  • > 1 episode of severe hypoglycemia in the last 6 months
  • Eligibility criteria:
Show all 13Show fewer
  • If the patient meets the inclusion criteria and does not present exclusion criteria, he/she may proceed to carry out physical evaluations to determine if has the conditions to perform the intervention. The patient may be ineligible for investigation in case of:
  • Upon completing the Cafra test, His/her heart rate is> or equal to 160 (20, 23)
  • If he/she shows blood pressure compatible with arterial hypertension before or after the initial physical evaluation.
  • Definition of arterial hypertension according to the recommendations of the American Academy of Pediatrics (30):
  • Blood pressure> or equal to the 95th percentile or> 130/80 mm Hg in adolescents greater than or equal to 13 years.
  • If he/she develops any signs of post-exercise musculoskeletal injury (functional impotence, pain or swelling joint)
  • In case they present a score ≥11 in the PHQ-9 questionnaire without mental health evaluation.

Trial locations and contacts

1 site in 1 country.

Chile1 site
  • Hospital Las Higueras

    Talcahuano, Concepcion, 4270918

Other trials in Chile

About this study

Patients with type 1 diabetes usually present cardiovascular risk factors. Sixty percent of them are overweight or obese, 40% have hypertension, 60% have dyslipidemia, leading to cardiovascular disease as the major cause of death in adults with type 1 diabetes. Regular exercise can help patients to improve cardiovascular disease risk profile, metabolic control and chronic complications. Recommendations for exercise in children with diabetes are the same as the general population, between ages 8 to 18 years 60 min of physical exercise/day is suggested, including moderate or vigorous aerobic activity (at least 20 minutes), muscle strengthening and bone strengthening activities. Children with type 1 diabetes have poorer physical fitness levels than the non-diabetic peers and it has been described some barriers to meet these recommendations between children and adolescents with type 1 diabetes such as the fear of hypoglycemia, external temperature, work schedule, loss of control of diabetes, a low fitness level. The two types of exercise (aerobic and anaerobic) are recommended in people with diabetes. High intensity interval training involves alternation between brief periods of vigorous exercise and recovery at low to moderate intensity. Has been shown that HIIT is associated with improving aerobic capacity without a detrimental decline in blood glucose in adults with type 1 diabetes and home-based high-intensity interval training reduces barriers to exercise in the same group. The objective of the present study is to propose a HIIT exercise protocol through online modality to a group of adolescents with type 1 diabetes to evaluate the metabolic effects and physical capacity through an analytical, prospective and longitudinal study (before and after) for 3 months. As primary outcome is expected to improve metabolic control shown as an increase in time in range on continuous glucose monitoring and a decrease in glycosylated hemoglobin. And as secondary results, improve the aerobic capacity and resistance strength, lipid profile parameters, anthropometric and on the mood of the participants.

Read the detailed description

Hypothesis Three month HIIT training program increases time in range (TIR) and decreases glycemic variability (MAGE) in adolescents with DM1.

HIIT training program improves physical fitness (aerobic capacity and strength) of adolescents with DM1.

Methodology Analytical, prospective, longitudinal study (before and after). This type of study was chosen for ethical reasons. A group will not be left without intervention knowing the benefits of physical exercise in patients with DM1.

HIIT for 3 months

Population of study This study will be carried out with adolescents with type 1 diabetes treated at the sponsoring Hospitals: Las Higueras and Guillermo Grant Benavente.

A sample size of 30 Adolescents would be sufficient to detect a 15 percent increase in the percentage of time in the range of glucose values within the target range four months after the study start using a level of significance of 0.05% a power of 80% and a loss of follow-up of 15% (4 adolescents).

Type of sampling Convenience sampling

Procedures

Metabolic control monitoring Continuous glucose monitoring (CGM) will be used continuously during the study period. The duration of the CGM is going to be 7 days each time (Guardian Connect, Medtronic). If the patients are already wearing a CGM, will use the same device and data from these specific times will be collected for analysis.

Blood glucose will be monitored during exercise to make adjustments to therapy if necessary. This will be done by the doctors weekly for the first month and then every 15 days.

The statistical analysis of the continuous glucose monitoring (CGM) will be carried out in 4 moments: before starting the study, the first month after, at 3 months and 3 months after ending the training.

Blood sampling is going to be taken at baseline and at 3 month. will be measured HbA1c and lipid profile.

Total insulin dosing is going to be carefully recorded as units/kg/day during the study.

An insulin sensitivity score (ISS) is going to be calculated using the SEARCH ISS model: logeIS = 4.64725 - 0.02032 × (waist, cm) - 0.09779 × (HbA1c, %) - 0.00235 × (TG, mg/dL; R2 = 0.74 in the initial SEARCH model). This has been validated using the hyperinsulinemic euglycemic clamp, considered the gold standard for insulin sensitivity measures. CGM data are going to be downloaded and used to calculate percent blood glucose at, below, or above target.

The HbA1c and lipid profile will be measured using the Abbott brand model Architect c8000.

Nutritional assessment Nutritional consultation is going to be performed to the participants, in which it will be carried out a body composition analysis using the bioimpedianciometer TANITA TBF-40 at several times: before starting the intervention, at 1 month, at 3 months and at 3 months after finishing the intervention.

Two educational sessions will be performed to participants and parents and / or caregivers on carbohydrate content and glycemic index to reinforce the knowledge acquired throughout the course of the pathology in order to contribute to improve glycemic control. These will be carried out through a digital platform divided into groups of 10 or 15 participants.

In order to know the daily calorie intake and the distribution of macronutrients of the participants, the information from the 24-hour reminder questionnaire will be collected through a telephone call in 4 random days (without prior notice) during the same evaluation times mentioned previously.

Fitness monitoring Before intervention the participants are going to undergo physical evaluation: Cafra test, course-navette test, strength and Physical activity questionnaire for adolescents (PAQ-a) to determine their health-related fitness before applying the protocol. To standardize the sample and avoid cardiovascular risks due to the intensity of the effort, the Cafra test will be applied, which will enable the participant to perform the following tests. This test is used in the evaluation of physical education by the Education Quality Measurement System in the country. At the end of intervention aerobic capacity and resistance strength is going to be evaluated again.

The Cafra test goal is to determine the cardiovascular adaptive capacity of the participants from workloads of medium intensity during walking. If at the end of the test the individual has a heart rate equal to or greater than 160 beats per minute, he should not take the Navette test.

The Navette test is a cardiorespiratory fitness test. The moment in which the individual interrupts the test indicates the cardiorespiratory endurance. In addition, at the time this test is performed, blood pressure will be measured before and at the end, to rule out the presence of baseline or exercise-induced hypertension.

The heart rate will be measured with a heart rate sensor, which indicates in real time the heart rate reached, during the initial and final evaluations and during training sessions.

To evaluate muscular endurance, the abdominal test will be performed in 60 seconds and the largest possible number of push-ups without rest will be carried out. In this way, there will be a record of how the physical condition is before and after applying the protocol.

Adherence to physical training and nutritional consultations will be monitored through the online connection.

Physical training The training is going to have 2 phases, the initial phase and improvement phase, which are going to be differentiated according to work intensity following the recommendations of the American College of Sports Medicine. To prescribe the intensity of exercise karvonen formula is going to be used for which resting heart rate measured for a week is needed.

The methodology of work is going to be High intensity interval training (HIIT) using cardiovascular and endurance exercises using the own weight considering an intensity of 60-75% of the VO2max during the first 4 weeks (initial phase). The frequency of the training is 3 times a week under researcher online supervision between 3 to 7 pm Monday to Friday. During the improvement phase the intensity is going to increase to a 75-85% of the VO2max for 8 week. The intensity and effects of the training will be monitored thought heart rate sensors and the Borg Rating of Perceived Exertion Scale. Post-exercise monitoring, class coordination, reminders and motivation to participate will be performed by online group administered by the researchers.

Two physical education teachers will supervise each session.

Strategies to avoid acute changes in glycemia during training

It will be required that participants check the blood glucose by fingerstick before meals, before and after exercise, at bedtime, and twice a week around midnight.

The amount and type of food are not going to be controlled, but will be asked participants not exercising before or within 90 minutes after a meal . Considering that HIIT is associated to stable glycaemia no changes will be prescribed in fast-acting insulin dose.

For the management of blood glucose levels during the training period (before, during and after each session), a protocol based on the recommendations of the consensus for glycemia management during exercise using continuous glucose monitoring will be used.

Before starting and after completing each training session, a capillary blood glucose measurement will be requested as a safety measure and also in the event of symptoms of hypoglycemia or if the sensor shows or anticipates hypoglycemia.

In addition, when participants first start exercising, according to the midnight glycemia, it may be necessary to reduce the basal insulin dose by 20-50% on the day of exercise.

Participants using an insulin pump will use the same protocol, with a reduction in bolus doses and use of temporary basal on the days of exercise.

Mood evaluation The Patient Health Questionnaire 9 (PHQ-9) will be applied in its version for adolescents, which consists of nine questions designed to evaluate depressive symptoms according to DSM-5 criteria, on an ordinal scale according to the frequency of symptoms (never, some days, more than half of the days, almost every day). The score range is from 0 to 27 points, where higher values indicate a greater probability of a Depressive Episode. This scale is graded into 4 categories: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderate to severe), 20-27 (severe). According to recent evidence, a score greater than or equal to 11 is recommended as a cut-off point to determine probable depressive episode in the Chilean population of adolescents. Patients who present a cut-off point higher than this in the initial evaluation will be excluded from protocol and will be referred to child psychiatry care.

To evaluate the effects of exercise on the depressed mood of adolescents, this survey will also be applied at the end of the intervention and 3 months after the intervention.

Blood Pressure Measurement In addition, during the initial evaluation, blood pressure will be measured before and after the physical tests to detect children with suspected hypertension, who as detailed above will be excluded from the intervention.

The BP recording will be carried out with an oscillometric device and the conditions for this procedure are: the adolescent must be seated, with the right arm uncovered, feet resting on the floor, and the BP cuff at the level of the heart. Before measuring the blood pressure the individual will need to remain sitting for at least five minutes. The blood pressure value will be evaluated according to the recommendations for the diagnosis of hypertension in children and adolescents of the American Academy of Pediatrics.

Statistical Analysis The initial analysis will examine data distribution through the Shapiro-Wilk test and baseline characteristics of all adolescents.

The quantitative variables will be expressed as means or medians, accompanied by deviation or interquartile ranges according to the exploration of normality. It will be analyzed each time of evaluation (transversal) using the chi-square test for categorical variables and the Student-t or Wilcoxon tests for continuous variables.

Relevant tests will be used to consider the non-dependence of the data obtained for both qualitative and quantitative analysis.

The effects of the treatment will be expressed , using mixed regression models (longitudinal) adjusting for potential confounders at baseline.

Subgroup analysis will be performed with interaction tests for relevant variables as BMI and socioeconomic status. Two separate definitions of compliance will be used. First, adolescents will be considered compliant to the HIIT treatment if participation is at least 75% of the number of training. Second, adolescents will be considered compliant to the HIIT if attendance is 100% of the counseling sessions to the nutritional and to endocrine consultations.

Outcome comparisons in the time will be analyzed intention-to-treat basis, regardless of whether is abandoned the study or fully adhere to the intervention. A secondary per-protocol analysis will be performed for the primary outcome including only the adolescents who were compliant with the protocol.

All analyses will follow a pre-specified statistical analysis plan. Stata v.14 software (StataCorp, College Station, TX) will be used for statistical analysis.

Being tested
HIGH INTENSITY INTERVAL TRAINING
Medical subject headings
Diabetes Mellitus, Type 1

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HIGH INTENSITY INTERVAL TRAININGOther

    Will be prescribed HIIT through online modality to a group of adolescents with type 1 diabetes 3 times a week for 3 months. The training is going to have 2 phases, the initial phase and improvement phase, which are going to be differentiated according to work intensity following the recommendations of the American College of Sports Medicine. During the initial phase (first 4 weeks) the intensity is going to be 60-75% of the VO2 max. During the improvement phase the intensity is going to increase to a 75-85% of the VO2 max for 8 week.

Study groups in NCT05107544
Study groupRoleWhat they receive
High Intensity Interval TrainingExperimentalThe entire group is going to be undergo the intervention
Receives: Other: HIGH INTENSITY INTERVAL TRAINING

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time change in range

    Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)

    Measured: First month after starting training

  2. Time change in range

    Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)

    Measured: Three months after starting training

  3. Time change in range

    Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in a target range (70-180)

    Measured: Three months after finishing training

Secondary outcomes (26)
  1. Change in hemoglobin A1c

    Blood test

    Measured: Three months after starting training

  2. Change in hemoglobin A1c

    Blood test

    Measured: Three months after finishing training

  3. Change in cholesterol

    Blood test

    Measured: Three months after starting training

  4. Change in cholesterol

    Blood test

    Measured: Three months after finishing training

  5. Change in triglycerides

    Blood test

    Measured: Three months after starting training

  6. Change in triglycerides

    Blood test

    Measured: Three months after finishing training

  7. Changes in systolic blood pressure

    Blood pressure monitor

    Measured: Three months after starting training

  8. Changes in systolic blood pressure

    Blood pressure monitor

    Measured: Three months after finishing training

  9. Changes in body composition

    The participant's weight will be taken with a calibrated scale

    Measured: Three months after starting training

  10. Changes in body composition

    The participant's weight will be taken with a calibrated scale

    Measured: Three months after finishing training

  11. Changes in body composition

    The participant's height will be taken with a tape measure

    Measured: Three months after starting training

  12. Changes in body composition

    The participant's height will be taken with a tape measure

    Measured: Three months after finishing training

  13. Changes in waist circumference

    The participant's waist circumference will be taken with a tape measure

    Measured: Three months after starting training

  14. Changes in waist circumference

    The participant's waist circumference will be taken with a tape measure

    Measured: Three months after finishing training

  15. Changes in aerobic capacity

    Will be done through the Navetta test

    Measured: Three months after starting training

  16. Changes in aerobic capacity

    Will be done through the Navetta test

    Measured: Three months after finishing training

  17. Change in heart rate

    It will be measured with a heart rate sensor, which indicates in real time the heart rate reached

    Measured: Three months after starting training

  18. Change in heart rate

    It will be measured with a heart rate sensor, which indicates in real time the heart rate reached

    Measured: Three months after finishing training

  19. Change in resistance strength

    It will be tested with repeated contractions for a period of time long enough for muscle fatigue to occur. The abdominal test will be performed in 60 seconds and the largest possible number of push-ups without rest will be performed

    Measured: Three months after starting training

  20. Change in resistance strength

    It will be tested with repeated contractions for a period of time long enough for muscle fatigue to occur. The abdominal test will be performed in 60 seconds and the largest possible number of push-ups without rest will be performed

    Measured: Three months after finishing training

  21. Change in total insulin dose

    Blood test

    Measured: Three months after starting training

  22. Change in total insulin dose

    Blood test

    Measured: Three months after finishing training

  23. Frequency of hypoglycemia episodes during the training

    A blood glucose meter will be used and trained to report episodes during workouts

    Measured: Three months after starting training

  24. Frequency of hypoglycemia episodes during the training

    A blood glucose meter will be used and trained to report episodes during workouts

    Measured: Three months after finishing training

  25. Change in mood of adolescents

    Application of the PHQ-9 questionnaire. This scale is graded into 4 categories: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderate to severe), 20-27 (severe) (25). A score greater than or equal to 11 is recommended as a cut-off point to determine probable ED in the Chilean population of adolescents

    Measured: Three months after starting training

  26. Change in mood of adolescents

    Application of the PHQ-9 questionnaire. This scale is graded into 4 categories: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderate to severe), 20-27 (severe) (25). A score greater than or equal to 11 is recommended as a cut-off point to determine probable ED in the Chilean population of adolescents

    Measured: Three months after finishing training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2021
  2. Study start4 Sep 2021
  3. Primary completion4 Mar 2022
  4. Study completion4 Apr 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05107544
Sponsor's protocol ID
20-12-67
Status last verified
Feb 2024
First submitted
11 Oct 2021
Last updated
28 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Miller RG, Mahajan HD, Costacou T, Sekikawa A, Anderson SJ, Orchard TJ. A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2016 Dec;39(12):2296-2303. doi: 10.2337/dc16-1162. Epub 2016 Sep 21.

    PubMed 27654986
  • Riddell, M., & Perkins B. (2006). Type 1 diabetes and vigorous exercise: Applications of exercise physiology to patient management. Canadian journal of diabetes, 30(1), 63-71.

  • MacMillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatr Diabetes. 2014 May;15(3):175-89. doi: 10.1111/pedi.12060. Epub 2013 Jul 29.

    PubMed 23895512
  • Katz M, Giani E, Laffel L. Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond. Curr Diab Rep. 2015 Dec;15(12):119. doi: 10.1007/s11892-015-0692-4.

    PubMed 26520142
  • Adolfsson P, Riddell MC, Taplin CE, Davis EA, Fournier PA, Annan F, Scaramuzza AE, Hasnani D, Hofer SE. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes. 2018 Oct;19 Suppl 27:205-226. doi: 10.1111/pedi.12755. No abstract available.

    PubMed 30133095
  • Kriska AM, LaPorte RE, Patrick SL, Kuller LH, Orchard TJ. The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study--VII. J Clin Epidemiol. 1991;44(11):1207-14. doi: 10.1016/0895-4356(91)90153-z.

    PubMed 1941015
  • Jabbour G, Henderson M, Mathieu ME. Barriers to Active Lifestyles in Children with Type 1 Diabetes. Can J Diabetes. 2016 Apr;40(2):170-2. doi: 10.1016/j.jcjd.2015.12.001.

    PubMed 27038139
  • Scott SN, Cocks M, Andrews RC, Narendran P, Purewal TS, Cuthbertson DJ, Wagenmakers AJM, Shepherd SO. High-Intensity Interval Training Improves Aerobic Capacity Without a Detrimental Decline in Blood Glucose in People With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Feb 1;104(2):604-612. doi: 10.1210/jc.2018-01309.

    PubMed 30281094
  • Scott SN, Shepherd SO, Strauss JA, Wagenmakers AJM, Cocks M. Home-based high-intensity interval training reduces barriers to exercise in people with type 1 diabetes. Exp Physiol. 2020 Apr;105(4):571-578. doi: 10.1113/EP088097. Epub 2019 Oct 25.

    PubMed 31584734
  • Reddy R, Wittenberg A, Castle JR, El Youssef J, Winters-Stone K, Gillingham M, Jacobs PG. Effect of Aerobic and Resistance Exercise on Glycemic Control in Adults With Type 1 Diabetes. Can J Diabetes. 2019 Aug;43(6):406-414.e1. doi: 10.1016/j.jcjd.2018.08.193. Epub 2018 Aug 30.

    PubMed 30414785
  • Clements MA, Foster NC, Maahs DM, Schatz DA, Olson BA, Tsalikian E, Lee JM, Burt-Solorzano CM, Tamborlane WV, Chen V, Miller KM, Beck RW; T1D Exchange Clinic Network. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes. 2016 Aug;17(5):327-36. doi: 10.1111/pedi.12295. Epub 2015 Jul 8.

    PubMed 26153338
  • Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV; T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015 Jun;38(6):971-8. doi: 10.2337/dc15-0078.

    PubMed 25998289
  • Hasan R, Perez-Santiago D, Churilla JR, Montes B, Hossain J, Mauras N, Darmaun D. Can Short Bouts of Exercise ("Exercise Snacks") Improve Body Composition in Adolescents with Type 1 Diabetes? A Feasibility Study. Horm Res Paediatr. 2019;92(4):245-253. doi: 10.1159/000505328. Epub 2020 Jan 31.

    PubMed 32007996
  • Quirk H, Blake H, Dee B, Glazebrook C. "You can't just jump on a bike and go": a qualitative study exploring parents' perceptions of physical activity in children with type 1 diabetes. BMC Pediatr. 2014 Dec 20;14:313. doi: 10.1186/s12887-014-0313-4.

    PubMed 25526774
  • Francois ME, Baldi JC, Manning PJ, Lucas SJ, Hawley JA, Williams MJ, Cotter JD. 'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance. Diabetologia. 2014 Jul;57(7):1437-45. doi: 10.1007/s00125-014-3244-6. Epub 2014 May 10.

    PubMed 24817675

Questions about this trial

What is this clinical trial studying?

A study testing HIGH INTENSITY INTERVAL TRAINING in people with Diabetes Mellitus, Type 1, run by Hospital Las Higueras at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time change in range (time frame: First month after starting training). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05107544, which also lists 29 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in